newsfilter
← Latest News
GlobeNewswire·

Key Narmafotinib Patent Granted in the U.S.

Highlights The Company has received a Certificate of Grant from the US Patent and Trademark Office for a key patent for the FAK inhibitor narmafotinibThe patent extends protection for narmafotinib to at least 2040